Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of ET-26 versus etomidate for induction of general anesthesia in elective surgery
ChiCTR2400083190Phase 2Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of methoxyethyl etomidate and etomidate (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Phase IIa proportion of subjects with successful induction of anesthesia and Phase IIb proportion of subjects successfully induced into anesthesia. Started Apr 2024; status: completed.
02
Drugs
methoxyethyl etomidateetomidate
Beyond the preview
Go deeper on ChiCTR2400083190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083190.